Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer von Danson, S, Ferry, D, Alakhov, V, Margison, J, Kerr, D, Jowle, D, Brampton, M, Halbert, G, Ranson, M

Volltext

Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1 von Danson, S.J., Johnson, P., Ward, T.H., Dawson, M., Denneny, O., Dickinson, G., Aarons, L., Watson, A., Jowle, D., Cummings, J., Robson, L., Halbert, G., Dive, C., Ranson, M.

Volltext

Lomeguatrib, a Potent Inhibitor of O 6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide... von Ranson, Malcolm, Middleton, Mark R., Bridgewater, John, Lee, Siow Ming, Dawson, Martin, Jowle, Debra, Halbert, Gavin, Waller, Sue, McGrath, Helen, Gumbrell, Lindsey, McElhinney, R. Stanley, Donnelly, Dorothy, McMurry, T. Brian H., Margison, Geoffrey P.

Volltext

Final results of a phase I clinical trial of the bioreductive drug RH1 von Danson, S., Johnson, P., Ward, T., Dawson, M., Denneny, O., Watson, A., Jowle, D., Sharpe, P., Dive, C., Ranson, M.

Volltext

Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP 1049C) in patients with advanced cancer von Danson, S, Ferry, D, Alakhov, V, Margison, J, Kerr, D, Jowle, D, Brampton, M, Halbert, G, Ranson, M

Volltext bestellen